Merck intends to market the first treatment against Covid-19

Merck MSD intends to market the first treatment against Covid-19. After the failure of the vaccine from the Institut Pasteur, the American laboratory should be the first to market an effective drug against Covid 19 that is easily usable. Molnupiravir, for which Merck MSD purchased the exclusive rights from a Miami biotech, Ridgeback Biotherapeutics. Having […]